EP 3090731 B1 20180919 - FORMULATIONS COMPRISING NANOPARTICULATE MELOXICAM
Title (en)
FORMULATIONS COMPRISING NANOPARTICULATE MELOXICAM
Title (de)
FORMULIERUNGEN MIT NANOPARTIKULÄREM MELOXICAN
Title (fr)
FORMULES À MÉLOXICANE NANOPARTICULAIRE
Publication
Application
Priority
- US 45070503 P 20030303
- EP 08006465 A 20040227
- EP 04785761 A 20040227
- US 2004005706 W 20040227
Abstract (en)
[origin: EP3434261A1] The present invention is directed to compositions comprising meloxicam. The stable meloxicam compositions comprise (a) nanoparticulate particles of meloxicam having an effective average particle size of less than about 2000 nm, (b) particles of meloxicam having an effective average particle size which is less or greater than about 2 microns; wherein said effective average particle size is different than the particle size of the nanoparticulate particles of meloxicam (a); and (c) at least one surface stabilizer. The invention relates also to uses of the composition.
IPC 8 full level
A61K 9/14 (2006.01); A61K 31/5415 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01)
CPC (source: EP US)
A61K 9/0019 (2013.01 - EP US); A61K 9/145 (2013.01 - EP US); A61K 9/146 (2013.01 - EP US); A61P 1/04 (2018.01 - EP); A61P 1/12 (2018.01 - EP); A61P 1/16 (2018.01 - EP); A61P 5/24 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 9/14 (2018.01 - EP); A61P 11/00 (2018.01 - EP); A61P 11/02 (2018.01 - EP); A61P 11/06 (2018.01 - EP); A61P 11/16 (2018.01 - EP); A61P 13/12 (2018.01 - EP); A61P 15/00 (2018.01 - EP); A61P 17/02 (2018.01 - EP); A61P 17/04 (2018.01 - EP); A61P 17/06 (2018.01 - EP); A61P 17/16 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 19/08 (2018.01 - EP); A61P 19/10 (2018.01 - EP); A61P 25/00 (2018.01 - EP); A61P 25/04 (2018.01 - EP); A61P 27/02 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61P 39/00 (2018.01 - EP); A61K 9/0056 (2013.01 - EP US); A61K 9/0095 (2013.01 - EP US); A61K 9/2059 (2013.01 - EP US); Y10T 428/2982 (2015.01 - EP US); Y10T 428/2985 (2015.01 - EP US); Y10T 428/2987 (2015.01 - EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
US 2004229038 A1 20041118; US 8512727 B2 20130820; AT E431131 T1 20090515; CA 2517679 A1 20050113; CA 2517679 C 20120410; DE 602004021107 D1 20090625; DK 3090731 T3 20190107; DK 3434261 T3 20201123; EP 1617816 A2 20060125; EP 1617816 B1 20090513; EP 3090731 A1 20161109; EP 3090731 B1 20180919; EP 3434261 A1 20190130; EP 3434261 B1 20201028; ES 2326085 T3 20090930; ES 2701673 T3 20190225; HU E040393 T2 20190328; JP 2007505154 A 20070308; JP 2011042670 A 20110303; JP 2012012397 A 20120119; JP 4891774 B2 20120307; JP 5548092 B2 20140716; WO 2005002542 A2 20050113; WO 2005002542 A3 20060126
DOCDB simple family (application)
US 78490004 A 20040224; AT 04785761 T 20040227; CA 2517679 A 20040227; DE 602004021107 T 20040227; DK 16161176 T 20040227; DK 18186018 T 20040227; EP 04785761 A 20040227; EP 16161176 A 20040227; EP 18186018 A 20040227; ES 04785761 T 20040227; ES 16161176 T 20040227; HU E16161176 A 20040227; JP 2006532300 A 20040227; JP 2010233858 A 20101018; JP 2011148037 A 20110704; US 2004005706 W 20040227